Full Press Release Details
Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference.
ALT
Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference
Key Takeaway: Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference
Price reaction · baseline $6.93 (2025-01-28 close) · hit after-hours · clean, no other ALT news in the window
day 0 close
+0.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight